GlassScriptPhysician profile
Jared M Intaphan
NPI 1639486160
$14,958.46
in general payments reported to CMS, 2019-2025
49 companies · $2,713 in 2025
The $2,713 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,366 · 2020: $1,474 · 2021: $1,422 · 2022: $2,611 · 2023: $1,813 · 2024: $2,560 · 2025: $2,713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,790 · Education: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,789.93 |
| Education | $296.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,306.14 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $1,390.16 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Veran Medical Technologies, INC. | $1,383.36 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,107.70 | 2019-2025 | Ofev, Combivent Respimat, Spiriva Respimat |
| Regeneron Healthcare Solutions, INC. | $1,012.78 | 2019-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $833.48 | 2020-2025 | Acthar |
| Genzyme Corporation | $714.58 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $662.69 | 2020-2025 | Glassia, Cuvitru, Hyqvia |
| United Therapeutics Corporation | $644.54 | 2021-2025 | Tyvaso, Tyvaso |
| Mylan Specialty L.P. | $429.64 | 2019-2024 | Yupelri |
| Csl Behring | $403.87 | 2019-2025 | Hizentra |
| Insmed, INC. | $389.95 | 2020-2025 | Arikayce, Brinsupri |
| Amgen INC. | $336.72 | 2021-2025 | Tezspire |
| Inari Medical, INC. | $252.16 | 2022 | |
| Grifols USA, LLC | $237.96 | 2021-2025 | Prolastin-C Liquid, Xembify |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $230.20 | 2020-2024 | Opsumit, Uptravi |
| Electromed, INC. | $228.36 | 2019-2023 | Smartvest |
| Genentech USA, INC. | $214.69 | 2019-2023 | Xolair |
| Vapotherm INC | $198.98 | 2021-2022 | |
| Verona Pharma, INC. | $187.07 | 2025 | Ohtuvayre |
| Ethicon INC. | $170.01 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $157.28 | 2022-2025 | Purified Cortrophin Gel |
| Pfizer INC. | $153.55 | 2024-2025 | |
| Viatris Specialty LLC | $136.84 | 2025 | Yupelri |
| Novartis Pharmaceuticals Corporation | $119.08 | 2019-2023 | |
| Astellas Pharma US INC | $117.43 | 2020-2025 | Cresemba |
| Gilead Sciences, INC. | $112.96 | 2021-2022 | |
| Harmony Biosciences LLC | $90.29 | 2021-2024 | |
| Philips North America LLC | $88.37 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $73.17 | 2024-2025 | Zerbaxa |
| Shire North American Group INC | $48.51 | 2019 | |
| Optinose US, INC. | $47.13 | 2020 | |
| Janssen Pharmaceuticals, INC | $43.76 | 2020 | |
| Pharming Healthcare, INC. | $42.49 | 2022 | |
| Stryker Corporation | $41.33 | 2025 | Ct Thrombectomy System Kit |
| Jazz Pharmaceuticals INC. | $39.88 | 2020-2021 | |
| Catalyst Pharmaceuticals, INC. | $34.31 | 2022 | |
| Mallinckrodt Enterprises LLC | $34.01 | 2019 | |
| Advanced Respiratory, INC | $33.94 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $29.30 | 2022 | |
| Circassia INC. | $26.13 | 2019 | |
| Shionogi INC | $23.26 | 2022 | |
| Sanofi-Aventis U.S. LLC | $21.88 | 2020 | |
| Inogen, INC. | $20.33 | 2024 | |
| Baxter Healthcare | $19.47 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Resmed Corp | $18.29 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $17.37 | 2025 | Lumryz |
| Teva Pharmaceuticals USA, INC. | $16.98 | 2023 | Airduo Digihaler |
| Scpharmaceuticals INC. | $16.08 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Intaphan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.